Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI +5.00%69 EV-to-EBIT is 17.27 as of Sep. 21, 2026, which is 22% above its 10-year median of 14.21. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 69/100 and a GF Value™ of ₹135.89 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 482 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 51.66% on this metric.
The historical rank and industry rank for QMS Medical Allied Services's EV-to-EBIT or its related term are showing as below:
NSE:QMSMEDI'
s EV-to-EBIT Range Over the Past 10 Years
Min: 3.94 Med: 14.21 Max: 91.11
Current: 17.27
During the past 5 years, the highest EV-to-EBIT of QMS Medical Allied Services was 91.11. The lowest was 3.94. And the median was 14.21.
NSE:QMSMEDI's EV-to-EBIT is ranked better than 51.66% of 482
companies
in the Medical Devices & Instruments industry
Industry Median: 17.95
vs NSE:QMSMEDI: 17.27
QMS Medical Allied Services (NSE:QMSMEDI) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
QMS Medical Allied Services's Enterprise Value for the quarter that ended in Jun. 2026 was ₹ Mil.
QMS Medical Allied Services's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹243 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QMS Medical Allied Services EV-to-EBIT Related Terms
QMS Medical Allied Services EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QMSMEDI vs ISRG, BDX, RMD: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's EV-to-EBIT falls into.
QMS Medical Allied Services's current Enterprise Value is ₹4,206 Mil.
QMS Medical Allied Services's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹243 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QMS Medical Allied Services (NSE:QMSMEDI) has a EV-to-EBIT of 17.27 as of Sep. 21, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on QMS Medical Allied Services and its competitors. This is 22% above median its historical median of 14.21. Over the past decade, QMS Medical Allied Services' EV-to-EBIT has ranged from 3.94 to 91.11. According to the industry distribution chart, QMS Medical Allied Services ranks #233 out of 482 companies in the Medical Devices & Instruments industry, placing it in the top 48.3%.
Is QMS Medical Allied Services' EV-to-EBIT too high?
QMS Medical Allied Services' current EV-to-EBIT of 17.27 is 22% above median its 10-year median of 14.21. Over the past 10 years, this metric has ranged from a low of 3.94 to a high of 91.11. The Medical Devices & Instruments industry median EV-to-EBIT is 17.95. QMS Medical Allied Services' value of 17.27 is 3.8% below this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #233 out of 482 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #233 out of 482 companies for EV-to-EBIT. This puts QMS Medical Allied Services in the upper half of its industry. The industry median EV-to-EBIT is 17.95. QMS Medical Allied Services' value of 17.27 is 3.8% below this benchmark. Historically, QMS Medical Allied Services' own EV-to-EBIT has ranged from 3.94 to 91.11 over the past decade. While the company's 10-year median is 14.21 vs. the industry median of 17.95, QMS Medical Allied Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 17.95, based on 482 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current EV-to-EBIT of 17.27 is 3.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 17.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current EV-to-EBIT is 17.27, which is 22% above median its own 10-year median of 14.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹135.89, compared to a current price of ₹177.36 — trading 30.5% above its estimated fair value. The current EV-to-EBIT is 17.27, which is 22% above median its 10-year median of 14.21 and 3.8% below the Medical Devices & Instruments industry median of 17.95. QMS Medical Allied Services' overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current EV-to-EBIT is 17.27 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be overvalued.
The current stock price of ₹177.36 is trading 30.5% above its estimated GF Value™ of ₹135.89.
GuruFocus considers QMS Medical Allied Services to be Significantly Overvalued.
Key valuation signals for NSE:QMSMEDI:
EV-to-EBIT: 17.27 (22% above median its 10-year median of 14.21)
GF Value™: ₹135.89 vs. price of ₹177.36 (30.5% above fair value)
Industry Position: 3.8% below the Medical Devices & Instruments median (#233 of 482)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
69GF Score
Get the complete analysis for NSE:QMSMEDI
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
